Time to Offer a Polypill to People Aged 50 or Over?

Linda Brookes, MSc; David S. Wald, MBBS, MD, FRCP


September 19, 2012

In This Article

A Best Evidence Interview With David S. Wald, MBBS, MD, FRCP

The Study

Wald DS, Morris JK, Wald NJ. Randomized polypill crossover trial in people aged 50 and over. PLoS One. 2012;7:e41297.

About the Interviewee

David S. Wald, MBBS, MD, FRCP, is Reader in Preventive Cardiovascular Medicine and Consultant Interventional Cardiologist at the Wolfson Institute of Preventive Medicine, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom. His clinical and academic aims are to bridge the interventional and preventive approaches to cardiovascular disease, which are often viewed as distinct. He coordinates the Polypill Prevention Programme, a novel service that adopts the polypill approach in coronary heart disease and stroke prevention. He has an interest in the development of a polypill.